Growth momentum Zymo Research is actively expanding its offerings with Zymo Services and collaborative ventures in 2026, signaling opportunities for bundled service contracts, consulting engagements, and long term partnerships with customers seeking integrated workflows.

Epigenetics leadership With a strong emphasis on epigenetics and a history of pioneering DNA and RNA purification technologies, there is a clear opening to upsell advanced epigenetics tools and services to labs expanding epigenetic research programs.

Pregnancy testing collaboration Current partnerships to develop cell-free DNA based early pregnancy tests suggest potential for expanding stochastic molecular diagnostics portfolios, enabling co-marketing, licensing deals, or joint development opportunities in liquid biopsy and maternal-fetal testing markets.

NGS and library prep Recent launches in sequencing workflows and transposase technology indicate demand for next generation sequencing solutions; sales opportunities exist for high-performance reagents, kits, and automation-compatible platforms supporting library preparation and sample processing.

Industrial and public health Participation in wastewater microbiology initiatives and broad R&D reach imply prospects for supply of nucleic acid purification and detection tools for environmental monitoring, public health surveillance, and contract research organizations.